(Date:11/24/2009)... The FBI recently approved the Prom... participating in or generating DNA records for th... Madison, WI USA (PRWEB) -- The FBI recently ... for use by laboratories participating in, or gene...tem (NDIS). NDIS currently contains more than seve...
(Date:11/24/2009)...DWOODCITY,Calif.,Nov.24/PRNewswire-FirstCall/--Gen...ndyScott,GenomicHealth,sExecutiveChairman,willpres...inNewYorkCityonTuesday,December1,2009at10:00a.m.ET...astofthepresentation,visittheInvestorRelationssect...michealth.com .Pleaseconnecttothewebsiteatleast15m...
(Date:11/23/2009)...KE CITY, Nov. 23, 2009 In a provocative new study...g carbon dioxide emissions the major cause of glo...,s economy collapses or society builds the equival..."It looks unlikely that there will be any substant...eleration in carbon dioxide emission rates," says ...
(Date:11/23/2009)...SSISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-YMBioSci...uctdevelopmentcompanythatidentifiesandadvancesadiv...riousstagesofdevelopment,todayreportedthatCytopia(...luatingCYT387,apotent,orally-administeredJAK1/JAK2...chester,Minnesota.AproposaltomergeCytopiaintoYMhas...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Genomic Health to Present at Piper Jaffray Health Care Conference 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4 Other News: